查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586180

細胞裂解/細胞分餾市場：按產品類型、細胞類型、應用和最終用戶 - 2025-2030 年全球預測

Cell Lysis/Cell Fractionation Market by Product (Consumables, Instruments), Cell Type (Mammalian Cells, Microbial Cells), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

細胞裂解/細胞分化市場2023年估值為33.5億美元，預計2024年將達到36.3億美元，複合年成長率為8.55%，到2030年將達到59.5億美元，預計將達到1000萬美元。

細胞裂解和細胞分級分離是分子生物學和生物化學中的重要技術，對於分離細胞成分以進行進一步分析至關重要。這些過程使科學家能夠破壞細胞（裂解）並分離其內部成分（分級分離），從而更容易研究蛋白質、核酸和其他分子。這些技術的需求源於它們在研究、醫學和診斷中的廣泛應用，從而促進了疾病理解、藥物開發和治療方法的進步。最終用途範圍廣泛，包括生物技術公司、研究實驗室、臨床應用以及專注於個人化醫療和基因組學的行業。市場成長受到研發投資增加、設備技術進步以及需要新療法的慢性病盛行率上升的影響。開發自動化、易於使用的設備以提高細胞分析的準確性和效率的機會比比皆是。人工智慧和機器學習在資料分析中的整合提供了一個充滿希望的前沿領域，探索更溫和的細胞裂解以保護脆弱的生物分子的新技術也是如此。然而，該市場面臨一些限制，例如高營運成本以及維持細胞完整性和污染風險的技術挑戰。生物技術領域的智慧財產權問題和嚴格的監管標準進一步增加了障礙。抓住機會的建議包括投資於降低製程複雜性和成本的創新，並專注於方法和材料的永續性。學術機構和生物技術公司之間的合作夥伴關係可以加速新方法的整合。創新也應著重於小型化和實驗室晶片技術，以解決資源有限環境中日益有價值的照護端應用問題。總體而言，這個市場被視為充滿活力但充滿挑戰，對於那些策略性地駕馭其複雜性的人來說具有巨大的潛力。

主要市場統計
基準年[2023] 33.5億美元
預測年份 [2024] 36.3億美元
預測年份 [2030] 59.5億美元
複合年成長率（%） 8.55%

市場動態：快速發展的細胞裂解/細胞分級市場的關鍵市場洞察

細胞裂解/細胞分餾市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 醫療保健、生命科學和製藥業的擴張
    • 增加政府對生命科學研究的資助
    • 愛滋病毒/愛滋病和癌症等疾病的流行不斷擴大
  • 市場限制因素
    • 細胞設備和研究成本上升
  • 市場機會
    • 對個人化醫療以及生物製藥和生物技術行業擴張的興趣日益濃厚
    • 醫療機構積極的研究活動
  • 市場挑戰
    • 缺乏受過訓練的細胞裂解/細胞分級人員

波特的五力：駕馭細胞裂解/細胞分級分離市場的策略工具

波特的五力架構是了解細胞裂解/細胞分級市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解細胞裂解/細胞分餾市場的外部影響

外部宏觀環境因素在塑造細胞裂解/細胞分餾市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解細胞裂解/細胞分餾市場的競爭格局

細胞裂解/細胞分級市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣細胞裂解/細胞分餾市場供應商的績效評估

FPNV定位矩陣是評估細胞裂解/細胞分餾市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了細胞裂解/細胞分級市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對細胞裂解/細胞分級市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大醫療保健、生命科學和製藥業
      • 增加政府對生命科學研究的資助
      • 愛滋病毒/愛滋病和癌症等疾病的盛行率增加
    • 抑制因素
      • 基於細胞的設備和研究高成本
    • 機會
      • 日益關注個人化醫療以及生物製藥和生物技術產業的擴張
      • 跨醫療機構強大的細胞裂解/細胞分級研究活動
    • 任務
      • 缺乏受過訓練的細胞裂解/細胞分級人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章細胞裂解/細胞分餾市場：依產品

  • 消耗品
    • 珠
    • 一次性的
    • 試劑和套件
  • 裝置
    • 均質器
    • 超音波儀

第 7 章按細胞類型分類的細胞裂解/細胞分餾市場

  • 哺乳動物細胞
  • 微生物細胞

第 8 章 細胞裂解/細胞分餾市場：依應用分類

  • 核酸精製與分離
  • 蛋白質精製與分離

第 9 章 細胞裂解/細胞分餾市場：依最終用戶分類

  • 生物製藥和生物技術公司
  • 研究室/實驗室

第10章美洲細胞裂解/細胞分餾市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太細胞裂解/細胞分餾市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的細胞裂解/細胞分餾市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Claremont BioSolutions, LLC
  • Covaris, LLC
  • Creative Biostructure
  • F. Hoffmann-La Roche Ltd.
  • Geno Technology Inc.
  • Invent Biotechnologies, Inc.
  • Merck KGaA
  • Microfluidics International Corporation by IDEX Corporation
  • Miltenyi Biotec BV & Co. KG
  • Norgen Biotek Corp.
  • NZYTech, Lda.
  • Parr Instrument Company
  • Promega Corporation
  • PromoCell GmbH
  • Qiagen NV
  • Qsonica LLC
  • STEMCELL Technologies Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FD3F12D5351C

The Cell Lysis/Cell Fractionation Market was valued at USD 3.35 billion in 2023, expected to reach USD 3.63 billion in 2024, and is projected to grow at a CAGR of 8.55%, to USD 5.95 billion by 2030.

Cell lysis and cell fractionation are vital techniques in molecular biology and biochemistry, essential for isolating cellular components for further analysis. These processes allow scientists to break open cells (lysis) and separate their internal constituents (fractionation), thereby facilitating the study of proteins, nucleic acids, and other molecules. The necessity of these techniques arises from their widespread application in research, pharmaceuticals, and diagnostics, enabling advancements in disease understanding, drug development, and therapeutic solutions. The end-use scope is expansive, spanning biotechnology firms, research labs, clinical applications, and industries focused on personalized medicine and genomics. Market growth is influenced by increased R&D investments, technological advancements in equipment, and the rising prevalence of chronic diseases necessitating novel treatments. Opportunities abound in developing automated, user-friendly equipment that enhances precision and efficiency in cell analysis. The integration of AI and machine learning for data analysis presents a promising frontier, as does exploring novel techniques for gentler cell lysis to protect fragile biomolecules. However, the market faces limitations such as high operational costs and technical challenges related to preserving cell integrity and the risk of contamination. Intellectual property issues and strict regulatory standards in biotechnology add further hurdles. Recommendations for seizing opportunities include investing in innovations that reduce process complexity and cost, and emphasizing sustainability in methods and materials. Collaborative partnerships between academic institutions and biotech firms can accelerate the integration of new methods. Innovations should also focus on miniaturization and lab-on-a-chip technologies to cater to point-of-care applications, which are increasingly valuable in resource-limited settings. Overall, the market is seen as dynamic but challenging, with significant potential for those who navigate its complexities strategically.

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.63 billion
Forecast Year [2030] USD 5.95 billion
CAGR (%) 8.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Lysis/Cell Fractionation Market

The Cell Lysis/Cell Fractionation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expanding healthcare, life sciences, and pharmaceutical industries
    • Increasing government funding for research in life sciences
    • Growing prevalence of diseases such as HIV/AIDS and cancer
  • Market Restraints
    • High cost of cell-based equipment and research
  • Market Opportunities
    • Growing focus on personalized medicine and the expansion of biopharmaceutical and biotechnology industries
    • Robust cell lysis/cell fractionation research activities across medical institutes
  • Market Challenges
    • Shortage of trained personnel for cell lysis/cell fractionation

Porter's Five Forces: A Strategic Tool for Navigating the Cell Lysis/Cell Fractionation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Lysis/Cell Fractionation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Lysis/Cell Fractionation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Lysis/Cell Fractionation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Lysis/Cell Fractionation Market

A detailed market share analysis in the Cell Lysis/Cell Fractionation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Lysis/Cell Fractionation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Lysis/Cell Fractionation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Lysis/Cell Fractionation Market

A strategic analysis of the Cell Lysis/Cell Fractionation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Lysis/Cell Fractionation Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Claremont BioSolutions, LLC, Covaris, LLC, Creative Biostructure, F. Hoffmann-La Roche Ltd., Geno Technology Inc., Invent Biotechnologies, Inc., Merck KGaA, Microfluidics International Corporation by IDEX Corporation, Miltenyi Biotec B.V. & Co. KG, Norgen Biotek Corp., NZYTech, Lda., Parr Instrument Company, Promega Corporation, PromoCell GmbH, Qiagen NV, Qsonica L.L.C, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Lysis/Cell Fractionation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents & Kits. The Instruments is further studied across Homogenizers and Sonicators.
  • Based on Cell Type, market is studied across Mammalian Cells and Microbial Cells.
  • Based on Application, market is studied across Nucleic Acid Purification & Isolation and Protein Purification & Isolation.
  • Based on End-User, market is studied across Biopharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries
      • 5.1.1.2. Increasing government funding for research in life sciences
      • 5.1.1.3. Growing prevalence of diseases such as HIV/AIDS and cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cell-based equipment and research
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on personalized medicine and the expansion of biopharmaceutical and biotechnology industries
      • 5.1.3.2. Robust cell lysis/cell fractionation research activities across medical institutes
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained personnel for cell lysis/cell fractionation
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Lysis/Cell Fractionation Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Beads
    • 6.2.2. Disposables
    • 6.2.3. Reagents & Kits
  • 6.3. Instruments
    • 6.3.1. Homogenizers
    • 6.3.2. Sonicators

7. Cell Lysis/Cell Fractionation Market, by Cell Type

  • 7.1. Introduction
  • 7.2. Mammalian Cells
  • 7.3. Microbial Cells

8. Cell Lysis/Cell Fractionation Market, by Application

  • 8.1. Introduction
  • 8.2. Nucleic Acid Purification & Isolation
  • 8.3. Protein Purification & Isolation

9. Cell Lysis/Cell Fractionation Market, by End-User

  • 9.1. Introduction
  • 9.2. Biopharmaceutical & Biotechnology Companies
  • 9.3. Research Laboratories & Institutes

10. Americas Cell Lysis/Cell Fractionation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Lysis/Cell Fractionation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Agilent Technologies, Inc.
  • 3. Beckman Coulter, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Cell Signaling Technology, Inc.
  • 7. Claremont BioSolutions, LLC
  • 8. Covaris, LLC
  • 9. Creative Biostructure
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Geno Technology Inc.
  • 12. Invent Biotechnologies, Inc.
  • 13. Merck KGaA
  • 14. Microfluidics International Corporation by IDEX Corporation
  • 15. Miltenyi Biotec B.V. & Co. KG
  • 16. Norgen Biotek Corp.
  • 17. NZYTech, Lda.
  • 18. Parr Instrument Company
  • 19. Promega Corporation
  • 20. PromoCell GmbH
  • 21. Qiagen NV
  • 22. Qsonica L.L.C
  • 23. STEMCELL Technologies Inc.
  • 24. Takara Bio Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. CELL LYSIS/CELL FRACTIONATION MARKET RESEARCH PROCESS
  • FIGURE 2. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL LYSIS/CELL FRACTIONATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL LYSIS/CELL FRACTIONATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 150. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 277. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2023